脑部放疗，上午比下午敏感许多！: G6 S0 ^" ], c7 s
% n9 A- }$ P# w* p. _' i
6 G. |3 f7 y# G! s+ YCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
$ d' p5 m1 K8 V) wGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?$ |( U' p& I- v9 M; `& c* g/ A
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.( ~ _! P- ~# x9 h' u8 |& m
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
! n3 N& O9 ^8 G* V! V7 J9 u/ B
& y$ y! d% ]0 I" J/ GAbstract4 t. Y& D4 {6 Q B$ o- f% [9 I
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
+ U, n2 E. w* u* I4 Y; l1 [5 m o0 p1 p& Z4 Z7 x( j
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
6 @, {3 U+ G+ m8 A& N; S8 L! _" X/ b2 @ c6 B, A$ K8 \
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026)." O0 Q/ T# B" U3 f% q. d# G
! I ^3 f+ Q" }; }/ d) O/ FCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
9 U0 K2 _! v+ J# E! h" I; }( l1 ~$ A8 s ?8 s1 I0 V7 ]
|
11011102001537 )
显身卡
